Sign In
Buy RWLK
$1.05
+0 (+0%)
At Close: Apr 26, 2024
ReWalk Robotics Files Revised Preliminary Proxy Statement and Issues Letter to Shareholders
08:10pm, Thursday, 26'th May 2022 GlobeNewswire Inc.
Highlights the Company’s Recent Progress and Momentum Towards Value-Enhancing Commercialization and Reimbursement
ReWalk Robotics Confirms Receipt of Director Candidate Nominations from Creative Value Capital
11:55am, Thursday, 19'th May 2022 GlobeNewswire Inc.
Shareholders Are Not Required to Take Action at This Time
ReWalk Robotics Ltd. (RWLK) CEO Larry Jasinki on Q1 2022 Results - Earnings Call Transcript
09:45am, Tuesday, 17'th May 2022
ReWalk Robotics Ltd. (NASDAQ:RWLK ) Q1 2022 Earnings Conference Call May 13, 2022 4:30 PM ET Company Participants Almog Adar - Director of Finance Larry Jasinski - CEO Conference Call Participants Mar
ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates
09:15pm, Friday, 13'th May 2022 Zacks Investment Research
ReWalk (RWLK) delivered earnings and revenue surprises of -40% and 60.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics Reports First Quarter 2022 Financial Results
08:05pm, Friday, 13'th May 2022 GlobeNewswire Inc.
CMS Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda includes the ReWalk Exoskeleton CMS Healthcare Common Procedure Coding System (HCPCS) Public Meeting Agenda includes the ReW
ReWalk Robotics (RWLK) Reports Q1 Loss, Lags Revenue Estimates
06:48pm, Friday, 13'th May 2022
ReWalk (RWLK) delivered earnings and revenue surprises of -40% and 60.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates
12:45pm, Thursday, 12'th May 2022 Zacks Investment Research
Neuronetics (STIM) delivered earnings and revenue surprises of 0% and 7.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
09:25pm, Monday, 09'th May 2022 Zacks Investment Research
Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022
08:15pm, Monday, 09'th May 2022 GlobeNewswire Inc.
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will
ReWalk Robotics to Report First Quarter 2022 Financial Results on May 13, 2022
04:15pm, Monday, 09'th May 2022
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will r
Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates
11:35pm, Wednesday, 04'th May 2022 Zacks Investment Research
Silk Road Medical (SILK) delivered earnings and revenue surprises of -17.07% and 5.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
10:45pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Masimo (MASI) delivered earnings and revenue surprises of 1.09% and 3.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Joins Israeli Technology Innovation Consortium for Human-Robot Interaction
12:30pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration through R&D grants The MAGNET Consortium program led by Israel’s Innovation Authority fosters collaboration
Accuray (ARAY) Reports Q3 Loss, Misses Revenue Estimates
10:35pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Accuray (ARAY) delivered earnings and revenue surprises of 83.33% and 3.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ReWalk Robotics Announces the Appointment of Joseph E. Turk, Jr. to their Board of Directors
08:05pm, Wednesday, 20'th Apr 2022 GlobeNewswire Inc.
Seasoned Medical Device professional brings 25 years of experience in commercializing novel technologies and in new business development Seasoned Medical Device professional brings 25 years of experie
